Events
Innovation in Healthcare: From Research to Market. SMEs in Focus
Sessions & Speakers
Square-Brussels Meeting Centre, Mont des Arts, 1000 Brussels, Belgium 20-21 May 2010
Thursday 20 May
09:00-10:15 - Welcome opening plenary (Copper Hall)
- Máire GEOGHEGAN-QUINN, Commissioner for Research, Innovation and Science
- Paola TESTORI COGGI, Director-General for Health and Consumers, DG SANCO
- Françoise LE BAIL, Deputy Director General for Enterprise & Industry, Commission's SME Envoy
- Cristina GUTIÉRREZ-CORTINES, Member of the European Parliament
10:45-12:00 - Innovation in Healthcare: The Stakeholders' view (Copper Hall)
- Simon Philipp HOERSTRUP, Head of Regenerative Medicine Programme and Professor of Biomedical Engineering, Zurich University
- Anders OLAUSON, President, European Patients' Forum
- John O'DEA, CEO, Crospon, Board Member of Irish Medical Devices Association (IMDA)
- Emmanuel CHANTELOT, Executive Director, European Biopharmaceutical Enterprises
13:30-15:30 - EU-funded health research: Creating opportunities for SMEs & Innovation (Silver Hall)
Moderator: Ruxandra DRAGHIA-AKLI Director, Directorate Health, Directorate-General for Research, European Commission
- Michel GOLDMAN, Executive Director, Innovative Medicines Initiative (IMI JU)
- Luuk BORG, Director of EUREKA Secretariat
- David SOURDIVE, Vice President of development corporate, Cellectis
- Jacques VISEUR, CEO, EuroTop
13:30-15:30 - Instruments in place to support SMEs applying for a marketing authorisation at the European Medicines Agency (Copper Hall)
Moderators: María FIGUEROLA, Pharmaceuticals Unit, DG Health and Consumers;
Ludovic LACAINE
, Director, Health Care Biotechnology Europabio
- Melanie CARR, Head of SME Office, European Medicines Agency, EMA
- Pavel BALABANOV, Scientific Administrator, Scientific advice section of the Human medicines, Special Areas sector, EMA
- María PASCUAL, VP Regulatory & Manufacturing, Cellerix
16:00-18:00 - Technology transfer: bringing healthcare-research to the market (Silver Hall)
Moderator: Christian SUOJANEN, Head of Life Sciences - Europe, Valor Management S.A., & Co-Chairman, Tech Transfer Summit
- Claes POST, Senior Business Developer, Innovation Office, Linköping University.
- Kari PAUKKERI, CEO, Licentia
- Pedro de NORONHA PISSARRA, CEO, Biotecnol SA.
- Manfred HORST, Licensing/Business Development, Merck & Co
- Peter RUILE, COO, Ascenion
- Hicham ABGHAY, Chairperson Healthcare Sector Group, Enterprise Europe Network, Steinbeis-Europa-Zentrum
16:00-18:00 - Experience of the centralised procedure, a case study of the Regulation on advanced therapies (Copper Hall)
Moderators : María FIGUEROLA, Pharmaceuticals Unit, DG Health and Consumers
María PASCUAL, VP Regulatory & Manufacturing, Cellerix
- Sol RUIZ, Committee for Human Medicinal Products / Committee for Advanced Therapies (AGEMED)
- Michelle LIPUCCI DI PAOLA, Eurordis
- Janneke de WAL, Director Clinical Development, Amsterdam Molecular Therapeutics
- Wilfried DALEMANS, CTO and VP Regulatory Affairs, Tigenix
- Lucia D'APOTE, Member of the Secretariat for the Committee for Advanced Therapies, EMA
Friday 21 May
09:00-10:30 - Is Open Innovation a solution for healthcare / life science? (Silver Hall)
Moderator: Frank HEEMSKERK, CEO, Research & Innovation Management Services
- Paul STOFFELS, Group Chairman of Pharmaceutical Research and Development, Johnson & Johnson
- J.W. (Hans) HOFSTRAAT, Vice President Philips Research, Healthcare Strategic Partnerships
- Gunnar MUENT, Head of Division, EIB
- Claire SKENTELBERY, Network Manager, Council of European Bioregions
09:00-10:30 - Access to finance for biopharmaceutical product development in Europe (Copper Hall)
Moderators: Giulia DEL BRENNA, Head of Unit Competitiveness in the pharmaceuticals industry and biotechnology, DG Enterprise and Industry, European Commission
Emmanuel CHANTELOT, Executive Director, European Biopharmaceutical Enterprises
- Tom SAYLOR, President & CEO, Arecor and Chair of EuropaBio's SME Platform
- Edwin MOSES, CEO, Ablynx and board member of European Biopharmaceutical Enterprises
- Michiel de HAAN, General Partner, Aescap Venture
- Mark de BOER, Partner, Index Ventures.
- Hakan GOKER, Associate, Atlas Venture
- William BROOKS , Investment Director Life Sciences Quest Management
- Florent GROS, Managing Director, Novartis Venture Funds
11:00-12:30 - Ingredients for innovation: research & entrepreneurship (Silver Hall)
Moderator: Frank HEEMSKERK, CEO,Research & Innovation Management Services
- Henriette VAN EIJL, Policy Officer, Innovation Policy Development, Directorate-General, Enterprise and Industry, European Commission
- Cristina GLAD, Executive Vice President, BioInvent International AB
- Ritchie HEAD , TrusTECH®
- Frederic ALLEMAND , Chief Business Officer, Biocortech
- Manuel GEA, Co-founder & CEO Bio-Modeling Systems, Vice-President, Innovation, Adebiotech
11:00-12:30 - The use of public financing instruments for innovation - at EU and national level (Copper Hall)
Moderators: Giulia DEL BRENNA, Head of Unit, Competitiveness in
the pharmaceuticals industry and biotechnology, DG Enterprise and Industry European Commission
Dirk CARREZ, Director EuropaBio
- Per-Ove ENGELBRECHT, Head of Unit Financing Innovation & SMEs, DG Enterprise and Industry, European Commission
- Piyush UNALKAT, Principal, EIF
- Michael BRANDKAMP, Managing Director, High-Tech Gruenderfonds
- Patrick CHATLIN, Leuven University
- Miran PLETERSKI, Director Corporate Advisory, PEMicon
Moderator: Christian SUOJANEN, Head of Life Sciences - Europe, Valor Management S.A., & Co-Chairman, Tech Transfer Summit
Reporting Panel:
Ruxandra DRAGHIA-AKLI
Giulia DEL BRENNA
Dirk CARREZ
Christian SUOJANEN
Frank HEEMSKERK
Emmanuel CHANTELOT
Maria PASCUAL
Ludovic LACAINE
CONCLUSION
José Manuel SILVA RODRIGUEZ
Director General for Research, European Commission